You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: June 18, 2025

Drug Price Trends for MUCUS RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MUCUS RELIEF

Best Wholesale Price for MUCUS RELIEF

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
MUCUS RELIEF Geri-Care Pharmaceutical Corp 57896-0794-01 60 1.58 0.02633 EACH 2022-11-15 - 2026-06-14 FSS
MUCUS RELIEF Geri-Care Pharmaceutical Corp 57896-0794-01 60 1.89 0.03150 EACH 2023-07-01 - 2026-06-14 FSS
MUCUS RELIEF Geri-Care Pharmaceutical Corp 57896-0794-06 60 1.58 0.02633 EACH 2021-09-18 - 2026-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Mucus Relief

Market Overview of Expectorant Drugs

The global expectorant drugs market, which includes products like Mucus Relief, is poised for significant growth. This market is projected to expand from $16.8 billion in 2023 to $22.9 billion by 2030, with a steady Compound Annual Growth Rate (CAGR) of 4.5%[1].

Role of Mucus Relief in the Market

Mucus Relief, containing the active ingredient guaifenesin, is a key player in this market. Guaifenesin is an expectorant that helps in thinning and loosening mucus, making it easier to cough up. This medication is commonly used for treating respiratory conditions such as bronchitis, bronchiectasis, and coughs[2].

Market Growth Drivers

The increasing prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma, is a primary driver for the growing demand for expectorant drugs like Mucus Relief. The need for effective symptom management and relief from respiratory distress is becoming more critical as these conditions become more widespread[1].

Dosage Forms and Market Segmentation

Oral solid forms, such as tablets and extended-release formulations, lead the expectorant drugs market due to their convenient delivery. Mucus Relief is available in various forms, including oral tablets and extended-release tablets, which cater to different patient needs and preferences[1][4].

Pricing and Cost Analysis

The cost of Mucus Relief varies depending on the dosage form and quantity. For example:

  • A supply of 60 Mucus Relief 400 mg oral tablets can cost around $11, which translates to approximately $0.18 per unit[2].
  • The extended-release version, Mucus Relief D (600 mg-60 mg), costs around $11 for a supply of 18 tablets, or about $0.62 per unit[4].

Generic versions of these medications are also available, which can be more cost-effective. For instance, a generic version of guaifenesin can cost as low as $9.90 for 20 tablets[2].

Discount Programs and Patient Assistance

To make these medications more affordable, discount programs like the Drugs.com Discount Card can save consumers up to 80% or more off the cost of prescription and over-the-counter drugs. These cards are accepted at most major pharmacies across the U.S.[2][4].

Market Size and Projections for Guaifenesin

The global guaifenesin market, which is a subset of the expectorant drugs market, is forecasted to grow at a CAGR of around 3.1% from 2022 to 2027, reaching a market size of USD 95 million by 2027. This growth is driven by the increasing application of guaifenesin in cough treatment drugs, particularly in hospitals and clinics[5].

Regional Market Analysis

North America is the fastest-growing region in the global guaifenesin market, with a CAGR of around 4.5% during the forecast period. This growth is influenced by the flourishing pharmaceutical sector and the development of medical infrastructure in the region[5].

Challenges and Opportunities

While the guaifenesin market faces challenges such as the availability of substitutes and potential side effects, it also presents significant opportunities. The growing demand in hospitals for cough treatment drugs, chest congestion medications, and other respiratory issues is driving the market forward. Advances in drug delivery and processing technologies are expected to further boost the growth prospects for guaifenesin[5].

Key Takeaways

  • Market Growth: The global expectorant drugs market, including Mucus Relief, is expected to grow at a CAGR of 4.5% from 2023 to 2030.
  • Pricing: Mucus Relief costs vary, but generic versions and discount programs can make it more affordable.
  • Regional Growth: North America is a key region driving the growth of the guaifenesin market.
  • Challenges and Opportunities: Despite challenges, the market is driven by increasing demand in hospitals and advancements in pharmaceutical technologies.

FAQs

1. What is the primary function of Mucus Relief in the respiratory system? Mucus Relief, containing guaifenesin, helps in thinning and loosening mucus, making it easier to cough up and facilitating easier breathing.

2. How is the global expectorant drugs market projected to grow? The global expectorant drugs market is projected to grow at a CAGR of 4.5% from 2023 to 2030, reaching $22.9 billion by 2030.

3. What are the common dosage forms of Mucus Relief? Mucus Relief is available in oral tablets and extended-release tablets, catering to different patient needs.

4. How can patients save on the cost of Mucus Relief? Patients can use discount programs like the Drugs.com Discount Card to save up to 80% or more off the cost of Mucus Relief.

5. Which region is driving the growth of the guaifenesin market? North America is the fastest-growing region in the global guaifenesin market, driven by the flourishing pharmaceutical sector and medical infrastructure development.

Sources

  1. GlobeNewswire - Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR[1].
  2. Drugs.com - Mucus Relief Prices, Coupons, Copay Cards & Patient Assistance[2].
  3. Allied Market Research - Guaifenesin Market Size, Trends | Industry Report 2021 - 2030[3].
  4. Drugs.com - Mucus Relief D Prices, Coupons, Copay Cards & Patient Assistance[4].
  5. IndustryARC - Guaifenesin Market Size Report, 2022-2027[5].
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.